KFDA articles & resources on Made-in-China.com

Cha Bio&Diostech Has Filed Its First Investigational New Drug (IND) Application

Jul 10, 2013

Cha Bio&Diostech, a South Korean partner of Pluristem Therapeutics, has filed its first investigational new drug (IND) application for Pluristem’s PLacental eXpanded (PLX) cells with the Korean Food and Drug Administration (KFDA). ...

Tags: PLX Cells, Cha Bio&Diostech

DNA Link Have Signed Powered by Affymetrix Program Agreement for Forensic Test Development

Feb 19, 2013

Affymetrix and Korean genomics-based biotechnology company DNA Link have signed Powered by Affymetrix (PbA) Program agreement for developing new molecular diagnostic tests for personalized healthcare. Under the agreement, DNA Link gained ...

Tags: DNA Link, forensic test development, molecular diagnostic tests

KFDA Approve BR Holdings Renaissance System

Dec 18, 2012

BR Holdings, a Korean distributor of Mazor Robotics, has received the Korean Food and Drug Administration (KFDA) approval to commercialize Mazor's Renaissance system. Renaissance system is a surgical guidance system that utilizes ...

Tags: KFDA, Mazor Robotic, Mazor's Renaissance system, medical application

Contraception Pills of Kfda are Allowed

Nov 27, 2012

The Korea Food and Drug Administration (KFDA) announced a re-categorisation plan for medicines, which allows emergency contraception pills, known as morning-after pills, to be sold OTC, while birth control pills will require a visit to the ...

Tags: KFDA, Emergency Contraception Pills, OTC Divison

KFDA

Cha Bio&Diostech Has Filed Its First Investigational New Drug (IND) Application

DNA Link Have Signed Powered by Affymetrix Program Agreement for Forensic Test Development

KFDA Approve BR Holdings Renaissance System

Contraception Pills of Kfda are Allowed

Related Products